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symptoms and signs of volume overload requiring intravenous diuretic therapy, were enrolled within 24 hours of admission. The protocol was approved by the ethics committee at each participating center, and patients provided written informed consent.
During the initial hospitalization, patients were assessed daily through the earlier of day 7 or discharge, followed up on day 14, and then contacted by telephone to identify death and readmission up to day 60 and to assess vital status alone at day 180. Investigators reported the occurrence of worsening heart failure (WHF) during the initial hospitalization based on worsening signs or symptoms of heart failure leading to intensification of HF-directed therapy. Samples for central laboratory assessment of chemistry and hematology were drawn daily through day 4 and then at day 7. Results of primary and secondary end points of PROTECT have been reported in detail. [9] For the purposes of this analysis, the following outcomes were considered: length of initial hospital stay, 30-day post-discharge all-cause readmission, 30-day post-discharge heart failure readmission, and 90-day post-discharge all-cause mortality.
Statistical Methods:
Patients in the intention-to-treat analysis set were excluded who were missing information about whether or not the patient had died during the initial hospital stay and therefore were missing a record for LOS. Length of stay is presented by patient status (survived or died during initial hospital stay) and by geographical region, showing means, standard deviations, medians, and first and third quartiles. For all subsequent analyses, patients who died during the initial hospital stay have been excluded. Because readmissions were assessed only through 60 days after baseline, patients with a LOS longer than 30 days were further excluded from analyses of 30-day post-discharge readmissions.
The following endpoints were considered for analysis: (i) LOS, (ii) 30-day post-discharge all-cause readmission, (iii) 30-day post-discharge HF readmission, and (iv) 90-day post-discharge all-cause mortality. Baseline characteristics are presented for patients who survived to discharge and further categorized as having a short, medium, or long LOS (supplementary tables). This categorization was determined based on the first and third tertiles within geographic region, which were 4 and 7 days in North America, 4 and 6 days in Israel, 8 and 13 days in Western Europe, 7 and 10 days in Eastern Europe, 4 and 6 days in Argentina, and 15 and 18 days in Russia. Baseline characteristics are further presented by all-cause readmission up to 30 days after discharge, by HF readmission up to 30 days after discharge, and by all-cause mortality up to 90 days after discharge (supplementary tables). For continuous baseline variables means, standard deviations, medians, and first and third quartiles are presented and differences between groups are compared using ANOVA F-tests. For discrete baseline variables absolute and relative frequencies are presented and proportions are compared between groups using chi-square tests.
Univariable and multivariable associations between baseline characteristics and each endpoint were assessed using linear regression (for LOS), logistic regression (for 30-day post-discharge readmission endpoints), and Cox proportional hazards models (for 90-day post-discharge mortality). Multivariable models were developed using a common approach. Non-linearity of the association between each continuous predictor and the outcome was assessed through testing the significance of non-linear components of a restricted cubic spline transformation. Plots of the predicted outcome against the value of the predictor and values of Akaike's Information Criterion (AIC) were used to select non-linear transformations where needed. From the 44 baseline variables considered (presented in the supplementary tables), four parameters (pulse pressure, mean arterial pressure, eGFR, and BUN/creatinine ratio) were excluded from further consideration due to correlation and/or collinearity issues. Multiple imputation assuming multivariate normality was used for missing predictors; the proportion missing each covariate is given in the supplementary tables. In each of the 10 imputed data sets, backwards selection was performed at a 0.05 significance level for linear regression and a 0.10 significance level for Cox and logistic regression models. Predictors selected in at least six of the ten imputed data sets were included in the final overall multivariable model. Estimated effect sizes, confidence intervals and p-values were obtained by averaging across the imputation datasets using Rubin's algorithm. [11] Model performance was assessed through adjusted R-squared for linear regression models and through C-statistics for logistic regression and Cox proportional hazards models.
C-statistics for Cox regression were computed using Harrell's method. [12, 13] Observed adjusted Rsquared and C-statistics were averaged across the 10 imputed data sets and further examined by obtaining bias-corrected estimates and corresponding confidence intervals using bootstrapping.
A multivariable-adjusted estimate of the association between LOS and the outcome of interest was obtained by adding the LOS as a predictor in the multivariable model. The occurrence of WHF up to day 7 after baseline was then added to evaluate whether any association between LOS and the outcome might be explained by WHF. In addition, changes from baseline to day 2 for certain laboratory parameters (albumin, AST, cholesterol, and creatinine) as well as for weight were added both individually and all at once into the model to determine how these parameters affect the association between LOS and the outcome of interest. Differences between models with added parameters were examined by obtaining bootstrap estimates and confidence intervals for the differences in adjusted Rsquared or C-statistics. All models were either adjusted or stratified by geographic region.
The rate of HF readmission as a function of days after discharge was evaluated using Poisson regression.
Patients were considered at risk until the first readmission for HF, last follow-up, or death. Due to the low number of events per day post-discharge, the model was not adjusted by geographic region. SAS® version 9.3 (SAS Institute, Cary, NC, USA) software was used for all analyses.
Results:
Between May 2007 and January 2009, 2033 patients were enrolled in PROTECT. . Of the 2021 patients in the intention-to-treat analysis set, 31 were excluded from analysis for whom deaths could not be classified as having occurred or not during the initial hospitalization. Therefore, no LOS value was available for these patients. For further analysis of LOS and all post-discharge endpoints, 88 patients who did not survive to discharge were excluded from the set of 1990 patients, leaving 1902 patients for analysis. For analysis of 30-day post-discharge readmissions, additional 53 patients whose LOS was > 30 days were excluded, leaving 1849 patients for analysis. shorter length of stay included male sex, history of HF, and higher systolic blood pressure, WBC, albumin and cholesterol (up to 4.5 mg/dl). Variables associated with longer LOS included history of angina pectoris, history of diabetes mellitus, higher BMI, higher heart rate (above 90 beats per minute at admission), more orthopnea and higher JVP, and higher BUN and Uric acid. In general the model had poor to modest ability to predict LOS in patients with AHF, with a bias-corrected adjusted R-square of 0.27. Adding to the model changes occurring during the first days of admission that representing congestion and end organ damage -such as AST, weight and creatinine changes, previously shown to be associated with post-discharge outcomes in protect [14] did not significantly improve the model. However, changes in markers of metabolic abnormalities such as Cholesterol and albumin and especially the occurrence of in-hospital WHF through day 7 increased the bias-corrected adjusted R-squared to 0.32 (95% CI 0.27, 0.35) which constitutes a significant increase of 0.050 (95% CI 0.028, 0.072), (table   2b) . Mean LOS was 15.2 days in patients with in-hospital WHF versus 9.8 days in patients without inhospital WHF.
LOS:
Readmission within 30 days after discharge: Baseline characteristics for patients who were or were not readmitted in the first 30 days post discharge are presented in supplemental table 2a, and baseline characteristics for patients readmitted for HF during the first 30 days after discharge are presented in supplemental table 2b. The HF readmission rate tended to follow a quadratic pattern of early increase during the first few days after discharge followed by a decrease (p=0.0458, figure 1 ). Multivariate predictors of all cause readmission 30 days after discharge were diabetes mellitus, presence of orthopnea but lack of edema and increased BUN (Table 3a ). The bias-corrected C-index for the model was 0.68 suggesting that the model had low predictive value. Longer LOS was borderline significant predictor for increased rate of all cause readmissions after discharge (p=0.0525) without improving the c-index of the model. Previous HF admission, orthopnea at admission, lower sodium, higher BUN and higher albumin were associated with an increased risk for HF readmission within 30 days after discharge (table 3b). The biascorrected C-index for this model was higher (0.74) than for all-cause readmission. Neither LOS nor occurrence of WHF were significantly associated with higher rates of 30-day post-discharge readmission and did not add predictive value to the model. Cumulative risks of post-discharge HF readmission by history of HF admission prior to the initial admission are presented in figure 2 .
90-day post-discharge mortality: Baseline characteristics of patients who died within 90 days of discharge are presented in supplemental table 3. Older age, history of lung disease, lower systolic blood pressure at admission, higher WBC count, lower sodium and bicarbonate and higher BUN and uric acid were associated with increased risk of mortality 90 days post discharge. Longer LOS, up to 14 days was associated with higher 90-day post-discharge mortality and this association persisted even after adjustment for WHF (table 4) as well as changes in albumin, AST, cholesterol, creatinine, and weight to day 2 (table 5). The model has modest discrimination for the outcome (bias-corrected c-index = 0.73).
Discussion
The journey of patients admitted for acute heart failure (AHF) through the hospitalization and early post-discharge period has been of significant interest in recent years as AHF has become an increasingly common cause for hospital admission [1] and admission for AHF is a large driver of the health cost associated with HF. Therefore, determining the drivers of longer LOS and, for patients being discharged alive, the drivers for early readmission and death has gained substantial importance.
Length of the initial hospital stay has been difficult to analyze because of its extreme variation among geographic regions [3] [4] [5] [6] . Indeed, in the present analysis LOS varied between 5-6 days in Argentina, Israel and the US to 17 days in Russia. After accounting for geographic region, the multivariable model to predict longer LOS had low to modest discrimination, meaning that for the most part variables such as baseline severity of HF, concomitant disease and lab abnormalities at admission did not predict well the LOS. Addition of in-hospital measures of changes in disease severity such as worsening of end organ (kidney, liver) function as well as change in weight, which in AHF patients mostly represents decongestion did not significantly improve the model, suggesting that these changes, did not add beyond HF and renal impairment severity at baseline to the patients length of stay. On the other hand, metabolic changes (change in cholesterol and albumin) and most significantly the occurrence of inhospital WHF increased the ability to predict length of stay (table 2b) . WHF was shown previously to be a strong predictor of LOS and short term outcomes in AHF [15] [16] [17] [18] and the current analysis adds substantially to this body of knowledge, reinforcing the strong interaction between occurrence of WHF in hospital in patients with AHF and prolonged LOS. These findings are of interest as they do not support our tendency in clinical practice to look at decongestion and weigh as well as changes in organ function -most importantly kidney function as important determinants of patient "dischargability". In reality, patients LOS is probably determined by severity of their disease and co-morbidities at baseline, however, during the hospital admission improvement in metabolic measures such as albumin and cholesterol and most importantly lack of occurrence of WHF are strong determinants of LOS, and hence it is possible that efforts to improve those measures and especially prevention of WHF should take precedence in our effort to shorten LOS.
Early post-discharge admissions (for all causes and HF) during the first 30 days after discharge were less common in the first days after discharge increasing after approximately a week and then decreasing slowly over time (figure 1). HF readmissions were largely predicted by whether patients were previously admitted for HF, disease severity (congestion, low sodium) and renal dysfunction. Previous HF readmission (figure 2) was an especially strong predictor of additional HF readmissions within 30 days post-discharge. Regretfully in the PROTECT study we did not collect any socioeconomic data to assess whether these factors contribute substantially to the rate of early HF readmission. However, by the fact that readmissions were common mostly very close to discharge and mostly predicted by previous HF admission, it would be reasonable to assume that early HF readmissions may occur preferentially in a subgroup of patients who tend to be hospitalized more -some because their HF and renal impairment are more severe, but as suggested previously [14] some because of socioeconomic parameters and some because of area of living [6, 17] . Interestingly, when examining the predictors of 90-day postdischarge mortality, although some predictors for HF readmission and death are similar (such as congestion at admission and kidney function), others are not (such as age, blood pressure, WBC count).
Most importantly increased length of stay remains a very significant predictor of 90-day post-discharge mortality, even after multiple adjustments for in-hospital deterioration of kidney or liver function or worsening of heart failure, but LOS is not a predictor of short term readmission, and especially HF readmission. Again, these associations suggest that to a certain degree a dichotomy exists in AHF between early readmission, and especially those for HF, and death. The current data as well as similar analysis of VERITAS [19] suggest that HF severity and more complicated hospital course are major drivers of post-discharge early mortality while early HF readmissions are driven by disease severity but possibly more so by a tendency of the patients to be repeatedly readmitted. If confirmed, this finding may have significant implications for targeting therapy. i.e., mortality should be targeted with the same tools aimed at improving heart failure and renal impairment, while readmission may need to be addressed by other interventions, aimed at patients who tend to be repeatedly admitted to hospitals.
Limitations
The current analysis is a retrospective analysis of the PROTECT study and hence limited to the patients who met the inclusion and exclusion criteria for the study and the variables collected in that study including only readmissions up to 60 days post discharge and no socioeconomic measures. The study was of relatively modest size and these results should be examined in larger prospective and possibly less selective patient populations.
Conclusions
For patients discharged alive from an admission for AHF, the main factors that are of importance to the patient and the health system as a whole are the length of initial hospital stay, and early readmission and death after discharge. The current analysis suggests that although heart failure and renal impairment contribute to prolonged LOS as well as increased rate of early readmission and death, other factors may contribute to the length of stay and tendency for early re-admission while early mortality is mostly driven by disease severity and comorbidities. These factors -in-hospital WHF for LOS and history of HF admissions for early post-discharge HF readmissions may prove important in targeting specific patients' subgroups for interventions aimed at reducing LOS and post-discharge readmissions. ------------------------------------------------Length of stay [1] ----------------------------------------- 5 (3.86), 140.0 (137.0 -142.0) 139. 5 (4.08), 140.0 (137.0 -142.0) 139. 1 (4.27), 140.0 (137.0 -142.0) 0.1300 Potassium, mEq/L 1750 (8.0%) 4.27 (0.573), 4.20 (3.90 -4.60) 4.27 (0.588), 4.20 (3.90 -4.70) 4.28 (0.564), 4.20 (3.90 -4.60) Albumin, g/dL 1842 (3.2%) 3.93 (0.408), 3.90 (3.70 -4.20) 3.79 (0.458), 3.80 (3.60 -4.10) 3.81 (0.421), 3.80 (3.50 -4.10 Glucose, mg/dL 1787 (6.0%) 7.79 (3.168), 6.99 (5.72 -8.88) 7.88 (3.397), 7.10 (5.61 -9.21) 7.87 (3.195), 7.10 (5.77 -9.10) 0.8774
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